Belinostat | compare suppliers & send inquiries for free
MOQ: 0 kg
Fresenius Kabi Onc.
Looking for Belinostat ?
Here you will find more information about Belinostat. Belinostat is a novel agent that inhibits the enzyme histone deacetylase (HDAC) with a sulfonamide-hydroxamide structure. It was developed as an orphan drug to target hematological malignancies and solid tumors by TopoTarget. The safety and efficacy of belinostat is currently being evaluated for use in combination with traditional front-line therapies for the treatment of PTCL.
Intravenous administration of the agent is available as Beleodaq as monotherapy and the dosing regimen involves a 21-day cycle. It was US-approved in July 2014 as a therapeutic agent for relapsed or refractory peripheral T-cell lymphoma.
Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements.
Belinostat manufacturers | traders | suppliers
We have 3 companies offering Belinostat from 2 different countries.
Get in contact with the supplier of your choice:
- MSN Labs. from India
- Fresenius Kabi Onc. from India
- Weijie Pharmaceuticals from China
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.